)
Visual
earnings real time
Micropos Medical
Micropos Medical (MPOS) investor relations material
Micropos Medical Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary30 Jan, 2026
Executive summary
Net sales for the year increased by 113% to 8,126 Tkr compared to 3,824 Tkr the previous year.
Result after financial items was -21,705 Tkr, a slight improvement from -21,868 Tkr last year.
The company achieved clinical acceptance for ASBRT with Raypilot System, with about 400 patients treated and strong customer satisfaction.
Eight new Raypilot Systems were installed during the year, with two installations in the US, expanding international presence.
The fourth quarter focused on strengthening customer relations, advancing clinical studies, and regulatory progress.
Financial highlights
Net sales for Q4 were 1,354 Tkr, down from 1,741 Tkr in Q4 last year.
Full-year net sales reached 8,126 Tkr, up 113% year-over-year.
Result after financial items for Q4 was -6,093 Tkr (Q4 2024: -4,577 Tkr); full-year result was -21,705 Tkr (-21,868 Tkr in 2024).
Equity at year-end was 13,729 Tkr (10,123 Tkr last year); soliditet improved to 72% (63%).
Cash flow for the year was 1,871 Tkr (1,951 Tkr in 2024); cash and bank at year-end was 9,841 Tkr (7,968 Tkr in 2024).
Outlook and guidance
The company expects continued growth as SBRT becomes more established, especially in markets like the UK, Spain, Italy, Austria, and Switzerland.
Capital injection will be needed in the first half of 2026 due to slow ramp-up in patient numbers.
Ongoing efforts to increase awareness and adoption of ASBRT and Raypilot System among patients and clinicians.
Strategy to accelerate patient treatment volumes?
Timeline for activating the 7 evaluation systems?
How to overcome surgery's dominance?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- DEVYANI
Revenue increased but net losses persisted; major acquisitions and amalgamation approved. - DNB
Q4 2025 saw strong growth and high returns, but annual profit fell due to higher costs and impairments. - DNBQ4 2025 profit NOK 11.6bn, 16.6% ROE, NOK 18 dividend, and strong CET1 at 17.9%.
- PARADEEP
Revenue and profit surged on higher volumes, MCFL merger, and expansion, with regulatory changes noted. - 2454
Q4 2025 saw strong revenue growth but lower net income and margins amid rising costs. - QBY
Profitability focus drives AI investment, international growth, and share buyback plans. - WRT1V
All-time high profit and cash flow, with robust Marine and Energy growth and key divestments. - NOBA
Record profit growth, robust capital, and SME expansion via acquisition in 2025. - 8354
Profit and net income rose over 15% YoY, with higher guidance and improved asset quality. - 4208
Operating profit surged 52% despite lower sales, driven by restructuring and acquisitions.
Next Micropos Medical earnings date
Q1 202630 Apr, 2026
Micropos Medical
Next Micropos Medical earnings date
Q1 202630 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Micropos Medical is a medical technology company specializing in the development of innovative solutions for precision radiotherapy in cancer treatment. The company focuses on improving the accuracy and efficiency of radiation therapy by offering advanced positioning and monitoring systems. Its technologies aim to enhance patient outcomes by enabling precise targeting of treatment areas while minimizing exposure to surrounding healthy tissues. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage